Healio

Icosapent ethyl appears to reduce inflammation, improve symptoms in COVID-19

Please provide your email address to receive an email when new articles are posted on . For the open-label COVID-19 Cardiolink-9 study, the researchers randomly assigned 100 symptomatic patients with ...
TCTMD

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Patients in the placebo arm of REDUCE-IT, who received mineral oil, saw worsening levels of numerous biomarkers linked to atherosclerotic disease during the trial, while those in the icosapent ethyl ...
Healio

Icosapent ethyl reduces coronary plaque at 18 months: EVAPORATE final results

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Icosapent ethyl as an adjunct to statin therapy ...
MedPage Today

Vascepa Mechanism Becomes Clearer... As Do Vessels

The mechanism behind the cardiovascular benefits of icosapent ethyl (Vascepa) was related to plaque regression and stabilization in people with atherosclerotic cardiovascular disease (ASCVD), ...
TCTMD

REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides

CHICAGO, IL—Icosapent ethyl (Vascepa; Amarin), a prescription omega-3 fatty acid formulation, reduces cardiovascular events in statin-treated patients with high triglyceride levels and either ...